By Dr. Juan Lopez Madrid, Chief Operating Officer, PharmCare Services.

In the intricate world of International Pharmaceutical Management (IPM), continuity of care is paramount. PharmCare Services stands as a vital link providing uninterrupted medication access across borders. Whether a patient begins in the U.S. or continues care in Latin America or Europe, our mission is clear: no disruptions, just better outcomes. This extends to foreign nationals, expats, and employees of global companies. Through PCSRx—our proprietary platform—these individuals have real-time access to a network of over 65,000 pharmacies spanning Latin America, the U.S., and parts of Europe. By aligning patients, specialists, insurers, and brokers in one real-time hub, we reduce care gaps, prevent unnecessary hospitalizations, and optimize disease management. We are that central “connective tissue” delivering seamless, cost-effective care—no matter where life takes you.

The Hidden Crisis of Global Mobility

For multinational companies, expatriates, and high-net-worth individuals, the world is increasingly borderless. However, when it comes to healthcare—and specifically, access to life-saving specialty medications—the borders are abruptly and rigidly enforced. While a diagnosis of a complex condition such as oncology, immunology, or a rare disease is universal, access to the highly specialized pharmacotherapy required to treat it is not. Outside the United States and the European Union, many specialty drugs are simply unavailable in local markets due to exorbitant stocking costs for local pharmacies, lack of infrastructure, or complex regulatory barriers. For an estimated 87% of international patients, crossing a border means encountering severe specialized medication access gaps.

Historically, this fragmentation has forced a disruptive and costly practice where patients managing chronic, high-acuity conditions endure frequent, exhausting travel back to the U.S. simply to receive an infusion or pick up a prescription. This places an immense physical, emotional, and financial burden on both the patient and their family, while stripping multinational employers of productivity, and costing international payers staggering sums in U.S. healthcare fees. Furthermore, the administrative hurdles of cross-border insurance claims and complex regulations can delay care from days into months. In the realm of specialty care, a delay is not just an inconvenience; it is a critical threat to a patient’s life.

The Connective Tissue of Global Healthcare

PharmCare Services was founded to overcome these barriers. We recognized that the international healthcare market needed a fiduciary bridge. Today, we operate as a “white-glove” international pharmaceutical manager (IPM), acting as the central connective tissue between fragmented global pharmacy networks, payers, and the patients who rely on them.

Our fundamental advantage lies in our unrivaled geographic reach and physical infrastructure. While competitors attempt to manage international cases remotely, PharmCare operates 10 active regional hubs and maintains local corporate entities across Latin America, including the Dominican Republic, Costa Rica, Colombia, Ecuador, Argentina, and Brazil. This on-the-ground presence is bolstered by a massive network of over 65,000 partner pharmacies in the U.S. and deeply vetted relationships with providers we collaborate with internationally.

This infrastructure allows us to do what others cannot: we deliver highly complex specialty therapeutics directly to a patient’s front door, or coordinate local hospital infusions, in as little as five business days—anywhere in the world.

Navigating the Regulatory Labyrinth

Securing specialty medication is only half the battle; ensuring it arrives safely and legally is another. Developing regions often suffer from a lack of pharmaceutical “pedigree,” meaning that unverified or illegitimate medications can easily infiltrate local supply chains.

PharmCare works to eliminate this risk. Our in-house compliance and medical affairs teams possess deep, multi-jurisdictional regulatory mastery across 12+ countries. We seamlessly navigate country-specific health authorities—from the FDA and EMA in the U.S. and Europe, to ANVISA, COFEPRIS, and INVIMA in Brazil, Mexico, and Colombia, respectively—ensuring that every medication we dispense comes from legitimate and regulated sources.

Technology-Enabled Continuity of Care

The backbone of our operation is our proprietary, real-time adjudication platform: PCSRx. Built specifically for the nuances of cross-border care, PCSRx normalizes complex data across different insurers and international regulatory environments, bringing clarity and efficiency to the global stage.

But PCSRx goes beyond claims processing, it is a clinical continuity tool. The platform is designed to track patient adherence predictively. Fifteen days before an international patient is scheduled to run out of their medication, our platform alerts our clinical coordination team. We proactively reach out to the patient to assess their therapy, discuss any side effects, and secure authorization for the refill from the payer. This proactive, concierge-level monitoring is designed to safeguard the continuity of life-sustaining therapies. By closely managing adherence, we help mitigate the risk of treatment lapses, ultimately working to prevent the medical emergencies and hospital readmissions that often stem from interrupted care.

Looking Ahead

The global market for specialty medicines is expanding rapidly, accounting for hundreds of billions of dollars annually, with a compound annual growth rate in the double digits. As the global expatriate population swells and multinational corporations expand into emerging markets, the demand for seamless cross-border healthcare will only intensify. PharmCare Services is already preparing for this future. This year, we are working on building up our infrastructure to better enable us to meet the needs of a truly globalized workforce.

In an industry where a single prescription can get lost in a labyrinth of borders, regulations, and fragmented networks, PharmCare provides a clinically minded solution. We do not just dispense medications; we deliver reliability, safety, and savings. Because at PharmCare Services, we believe that no matter where your life or business takes you, your standard of care should never have to compromise.

By Johan Porto Chief Financial Officer, PharmCare Services.

In the complex and often fragmented world of International Pharmaceutical Management (IPM), the journey of a single prescription can feel like a labyrinth. A patient receives a diagnosis, a prescriber writes a script, a claim is submitted to an insurance company, a broker might be notified, and finally, the medication is hopefully delivered to the patient. Each step is a hand-off, and at every transition point, the potential for miscommunication, delay, and frustration grows. What should be a straightforward process can quickly escalate into a crisis, and for those with serious or chronic conditions, timely access to medication is not just a matter of convenience, it’s a matter of health.

Enter PCSRx, the state-of-the-art pharmaceutical management platform from PharmCare Services. Medical professionals are constantly seeking new ways to streamline processes, reduce administrative burden, and, most importantly, improve patient outcomes. PCSRx is a breakthrough technology that promises to do just that, acting as a unified command center for the entire pharmaceutical management ecosystem.

A New Era of Transparency and Connectivity

The core problem in the current system is a lack of real-time, shared information. The patient might be in the dark about the status of their claim, the broker or authorized representative might not have the latest updates from the insurance company, and the provider may not know if the prescription has been filled. This disconnect can lead to a cascade of phone calls, emails, and faxes, with each party trying to piece together the full picture.

PCSRx changes this fundamentally. It provides a single, centralized platform where everyone who has been authorized—patients, payers, brokers, prescribers, and providers—can access the information they need, in real-time. This isn’t just a simple tracking system; it’s an intelligent, interactive hub that provides a clear delineation of each claim by its stages in its life cycle.

Imagine a patient checking an app on their phone and seeing that their claim is currently in the “insurance review” stage, with an estimated approval time. The prescriber can log in and see that a prior authorization request has been submitted and can easily provide any necessary additional information. The payer can view the claim and its supporting documentation instantly, and the provider can confirm where the medication is, on its way to anywhere in the world. The guesswork and the delays are gone.

Data-Driven Insights and Cost Containment

Beyond its ability to enhance communication, PCSRx is a goldmine for data analysis. The platform’s easy-to-understand data graphics provide powerful insights for payers and other stakeholders. By tracking every step of the claim process and analyzing the flow of medications, PCSRx can help identify trends, pinpoint inefficiencies, and highlight opportunities for cost containment.

For payers, this is an invaluable tool. They can analyze data on medication utilization, track claim denial rates, and understand the administrative costs associated with different types of claims. This information allows them to make more informed decisions about formulary design, benefit plans, and cost-containment strategies. The result is a more efficient system that not only saves money but also ensures that patients have access to the most effective and affordable treatments.

Global Live-Tracking: A New Standard of Care

One of the most remarkable features of PCSRx is its global live tracking of medications. This feature significantly reduces the time it takes for claims to be processed by replacing a fragmented, email-based communication system with a unified, real-time platform. This increased speed of communication and claims processing directly promotes better health outcomes for patients by ensuring faster access to medication. Patients with chronic or acute conditions who need timely medication will no longer face dangerous gaps in their treatment. Ultimately, these improved health outcomes lead to a significant reduction in overall costs for payers, who can prevent minor issues from escalating into healthcare emergencies that require expensive interventions, hospital stays, or specialized care.

For patients with complex or highly specialized therapies, particularly those who may be traveling or receiving care across international borders, this feature is a pivotal advancement. It provides a level of security and peace of mind that was previously impossible. The platform allows all parties to monitor the medication’s journey from the pharmacy to the patient, ensuring that it is delivered on time and in the correct condition. This is especially critical for temperature-sensitive medications or those with a short shelf-life. This real-time visibility helps prevent delays, addresses potential issues before they become critical, and ensures continuity of care, no matter where the patient is located.

The Future of Pharmaceutical Management

PCSRx is more than just a piece of software; it’s a paradigm shift. It replaces a disjointed, confusing, and often frustrating system with one that is transparent, connected, and efficient. By putting real-time information at the fingertips of everyone in the pharmaceutical management ecosystem, it helps prevent routine issues from escalating into healthcare emergencies and dramatically reduces the administrative and clerical burden on all involved. This is the future of pharmaceutical care—a future where technology empowers us to work together, so we can focus on what matters most: the health and well-being of our patients.

By Zachary Blaisdell Care Coordination Manager, PharmCare Services

The Hidden Crisis for Expatriate Employees

For multinational companies and leaders of global commerce, the world is their workplace. As your company expands its global footprint, your human resources and benefits teams face an obstacle that is often overlooked but profoundly impacts the health and productivity of your most valuable assets: your international employees. While global commerce is complicated, global healthcare—especially the management of specialty medications—is even more so.

Imagine a valued team member, essential to an overseas project, who manages a chronic, complex condition such as rheumatoid arthritis, multiple sclerosis, or a complex cancer. These conditions often require specialty medications—high-cost, complex drugs that typically demand special handling, administration, and ongoing clinical support.

For too long, the accepted reality was that an employee requiring such treatment had only one viable option: frequent, disruptive travel back to the United States every one to three months just to fill or receive their life-saving or life-sustaining prescription. This process is not only incredibly costly in terms of travel and lost productivity, but it also places a significant, constant burden on the employee’s physical and mental well-being, compounding the stress of managing a serious illness in a foreign country.

This simply is not a sustainable model for a healthy, secure, and productive global workforce. Quality healthcare shouldn’t stop at the border.

Introducing International Pharmaceutical Management (IPM)

At PharmCare Services, we recognized this critical gap and developed an innovative, clinical-first solution to eliminate the need for recurrent “medication tourism.” We call this specialized service International Pharmaceutical Management (IPM).

The mission of IPM is simple: We oversee the provision of medications, particularly specialty medications, worldwide, with a commitment to safety and integrity.

As a multinational team of doctors, nurses, pharmacists, and business professionals, we manage both the essential clinical support and the complex logistics of specialty drug distribution abroad.

Our Clinical Foundation: Comprehensive Care

Our service is built on a robust clinical foundation that ensures continuity of care, safety, and adherence for your employees, no matter their location. We handle the intricacies that go far beyond simple fulfillment:

• Prescription Verification: Ensuring prescriptions meet international standards and local requirements.
• Patient Follow-up: Providing ongoing support and education to maximize adherence and manage side effects.
• Provider Consultation: Communicating directly with US and foreign providers to coordinate care and manage therapy changes.
• Insurance Communication: Streamlining the complex process of benefit verification and prior authorizations for high-cost treatments.
• Pharmacovigilance: Implementing systematic processes for monitoring the safety of medicines along their journey to patient use.

This clinical oversight is seamlessly integrated with the necessary supply chain management, which requires navigating an intricate web of international regulations, customs clearance, and specialized transport. Specialty pharmaceuticals often require cold-chain logistics to ensure their efficacy is maintained upon arrival. We’ve become experts in handling this entire, end-to-end process.

We handle these complex cases on a daily basis and have built a robust infrastructure with physical locations in the United States, Latin America, and Europe, giving us access to a network of over 65,000 pharmacies worldwide.

Conclusion: Health, Security, and Global Productivity

The challenge of providing specialty medications to American employees abroad is no longer an unsolvable logistical hurdle. For multinational corporations, ensuring that a serious illness doesn’t also mean a serious disruption to an employee’s life—or to the company’s operations—is a crucial element of a modern benefits package.

Through our International Pharmaceutical Management (IPM) service, PharmCare Services delivers a comprehensive, clinical-first solution. We replace the stress and expense of frequent international travel with a system built on expert clinical management—from prescription verification and provider consultation to ongoing patient follow-up and pharmacovigilance—all backed by our global network and specialized logistics expertise.

Our mission is to make life easier for you and, most importantly, for your employees who are working hard for you abroad. By providing this essential support, we help ensure your international workforce is healthy, secure, and can focus on their jobs without the added stress of managing their medication from thousands of miles away.

At PharmCare Services, we are your dedicated partner in global health and wellness. Let us help you take care of your people, wherever they are, and realize the true potential of your global team.

By Dr. Raciel Rizo, MD, Regional Medical Director, Latin America, PharmCare Services

When it comes to healthcare in Latin America, the conversation often revolves around access, infrastructure, and cost—but few recognize the intricate challenge that lies at the core of ongoing care management: pharmacotherapy. As the Medical Director overseeing several nations in this part of the world, I’ve seen firsthand how medication management—seemingly straightforward in well-integrated health systems—becomes a puzzle of logistical, regulatory, and clinical complexity across borders.

Disparities Between Knowledge and Practice

Physicians throughout Latin America are highly motivated and increasingly well-informed. Many attend global medical conferences, complete continuing education, and stay current with the latest treatment guidelines. In theory, our clinicians are ready to offer best-in-class care. In practice, however, they are often constrained by the realities on the ground.

A doctor in Argentina may want to prescribe a cutting-edge biologic for a patient with rheumatoid arthritis—yet that medication may not be registered locally, or worse, it’s approved but entirely unavailable due to market withdrawals or pricing issues. A physician in Paraguay may understand the ideal GLP-1 agonist for a patient with obesity and metabolic syndrome but lack the ability to source it reliably, making adherence and therapeutic success nearly impossible.

Regional Barriers: From Infrastructure to Regulation

Latin American countries operate under varying regulatory frameworks, pricing controls, reimbursement structures, and distribution systems. This mosaic leads to unequal access to medications that are standard of care elsewhere. The result? Clinicians are left improvising, modifying treatment plans to fit what’s accessible—not what’s optimal.

To complicate matters further, there’s a lack of harmonization in how medications are handled across borders. Cold chain requirements, specialty handling needs, and controlled substance regulations all add friction that few insurers or policymakers see, but all prescribers feel.

For international payers and TPAs (Third-Party Administrators), these issues can lead to claim delays, prior authorization conflicts, and unexpected cost escalations—simply because the reality on the ground diverges so widely from what clinical guidelines and policy documents assume.

Bridging the Gap with Collaborative Expertise

This is where strategic collaboration becomes not just helpful, but essential.

At PharmCare Services, we’ve developed a model that supports physicians with cross-border expertise and real-world logistics. Our team includes physicians, pharmacists, and operational experts from multiple countries and specialties who work together to align the clinical ideal with what is feasible in each market. To enhance our efforts, we’ve also established a state-of-the-art international pharmaceutical management (IPM) platform, PCSRx.

This platform serves as a critical extension of our team’s work, helping to facilitate our services by connecting patients, prescribers, and payers in real time. It enables our experts to more efficiently access the information needed to navigate complex challenges. We don’t simply look at a prescription as a “yes or no” choice; we use the platform to help identify therapeutic alternatives when a first-line agent is unavailable, navigate regulatory pathways to dispense critical therapies when needed, and ensure cold-chain integrity and pharmacovigilance protocols are followed.

By leveraging our team’s expertise and the supportive functions of the PCSRx platform, we relieve a major burden from both physicians and insurers, allowing them to focus on care instead of procurement, as well as avoid unnecessary costs, misaligned approvals, or treatment abandonment due to medication unavailability.

A Call for Alignment

If there is one message I would deliver to the international private insurance community, it’s this: managing specialty pharmacotherapy in Latin America is not just about approving the right drugs—it’s about understanding the real-world limitations in distributing, dispensing, and maintaining those therapies across fragmented systems.

The solution is not always tighter policy—it’s closer cooperation with those who understand the clinical and logistical terrain.

With coordinated efforts between prescribers, PharmCare Services’ multi-national clinical team, and international payers, we can transform pharmacotherapy from a pain point into a point of partnership—improving outcomes for patients and reducing inefficiencies for payers alike.

About the Author

Dr. Raciel Rizo, MD, serves as the Regional Medical Director for PharmCare Services within Latin America, where he oversees cross-border clinical operations and care strategy. With over 20 years of experience in internal medicine and health system leadership, Dr. Rizo is committed to advancing equitable access to therapies across Latin America.

Written by Juan Lopez Madrid, MD, MPH, Director of Strategic Partnerships and Implementation Latam, PharmCare Services.

As pioneers in International Pharmaceutical Management (IPM), it’s our job to stay informed on the ever-evolving world of the pharmaceutical industry. The landscape of medicine has undergone a radical transformation, particularly in the last two decades, with incredible advancements in manufacturing and drug development. Yet, these innovations have also brought about a new level of complexity and cost.

The Soaring Cost of Pharmaceuticals

The landscape of medical care is constantly evolving, but one trend has become increasingly clear: the soaring cost of prescription drugs. As a healthcare professional, I’ve seen firsthand how this impacts both patients and the system as a whole. It’s a critical issue that deserves our full attention.

The American Academy of Actuaries projects that spending for retail prescription drugs will be the fastest-growing healthcare category over the next decade, consistently outpacing other health spending.² In 2023, for example, the median annual price for new drugs was $300,000, an increase of 35% from the previous year.⁴ This rapid growth is driven by several key factors:

Increasing Utilization: This includes the use of new drugs and increased prescribing for additional conditions.

Rising Unit Costs: New branded therapies often debut above the treatments they replace, and pricing is rarely a simple equation. It reflects improved clinical value, but also increased manufacturing complexity, fluctuating availability, and transport considerations.

Changes in Drug Mix: There is a shift toward more costly drugs, particularly specialty pharmaceuticals.

Specialty drugs—which are often high-cost, high-complexity medications—are a significant driver of this trend. They typically have higher prices than traditional brand and generic medications. The introduction of these highly effective, but very expensive, treatments is a major contributor to the rise in unit costs and overall spending.

Navigating the Claims Labyrinth

Over the past few decades, regulations have grown more robust, driven by public health crises and the need to ensure the safety and efficacy of medications. While these protections have been vital, the speed of change in drug manufacturing, distribution, pharmacovigilance (the tracking of drug safety), and pharmacotherapeutic monitoring have been staggering. The complexity behind the newer medications has also increased tremendously. Take, for instance, the current FDA pipeline: almost everything in development are new biologics and immunotherapies. This rapid climb in regulation and complexity has contributed to a dramatic increase in costs, as well as creating significant challenges and confusion for patients and insurance providers alike.

Within the international insurance industry, a key source of confusion lies in the distinction between pharmaceutical and medical claims. While they are both essential to a patient’s care, they are fundamentally different, and their differences have only been exacerbated by the complexities introduced to the industry in the last 20 years. Yet, these claims are often mishandled by still being treated as the same, with a blanket approach.

Medical claims typically cover services or procedures performed by a healthcare professional, such as a doctor’s visit, a surgical procedure, or a hospital stay.

Pharmaceutical claims, on the other hand, cover prescription medications dispensed by a pharmacy, and the services linked to the administration and monitoring of these therapies at a medical facility, in an ambulatory setting, or even at a patient’s home for infusion.

The crucial problem is that the detailed nuances of each claim type are frequently ignored. Pharmaceutical claims involve specific product information, dosage, and regulatory requirements that are completely different from a medical procedure. When these distinct claim types are lumped together, the system breaks down. This “one-size-fits-all” approach leads to a host of inefficiencies, including claim denials, delays in patient care, and a lack of proper financial oversight. The absence of specialized care and attention to the unique intricacies of each claim is a major contributor to the soaring costs and administrative burden in the healthcare system. These problems are significant on an individual, national level, but become greater on a global scale, and even furthermore complicated when dealing with specialty medications and their availability disparities.

PharmCare Services: A Prescription for the Industry

This is where the innovative solutions provided by PharmCare Services can make a profound difference. As an International Pharmaceutical Manager, we are designed to address the very complexities that plague the industry.

PharmCare Services helps to fix these problems by:

Streamlining Claims Management: We use an advanced technological platform to manage international pharmacy claims, providing global, real-time updates that reduce the administrative burden and help ensure accuracy.

Enhancing Patient Care: Beyond simply processing claims, we provide a suite of patient-focused services, including personalized medication management plans, adherence programs, and 24/7 support for those on complex therapies.

Controlling Costs: We employ sophisticated cost-containment strategies, leveraging a vast distribution network to ensure medication accessibility and traceability, all while working to optimize costs for international insurance companies and their patients.

By using the specialized services of PharmCare Services for pharmaceutical claims and management, instead of relying solely on a single TPA for a blanket approach to both medical and pharmaceutical claims, the greatest level of care can be achieved. This approach ensures that the unique intricacies of pharmaceutical claims are properly handled by experts. When you combine this specialized expertise with cost-management strategies, it leads to a more cohesive and effective healthcare system. We help ensure that patients receive the right medications at the right time, without getting lost in a fragmented and costly system.

Conclusion

The journey through the pharmaceutical landscape is a complex one, marked by groundbreaking innovation and escalating costs. The rise of sophisticated specialty drugs and a convoluted claims process has created a system fraught with inefficiencies, delays, and financial strain for both patients and providers.

The solution is not to halt progress, but to adapt our systems to meet the challenges presented by these advancements. By embracing specialized pharmaceutical management, we can untangle the administrative chaos and restore focus to what truly matters: the patient. PharmCare Services represents a vital shift in this direction, providing the expertise and technology needed to ensure that the promise of modern medicine is not overshadowed by the price of its delivery.

We believe that a more informed, streamlined, and patient-centric approach to pharmaceutical management is not just a business opportunity—it’s a moral imperative. By ensuring that pharmaceutical claims are treated with the unique attention they deserve, we can create a more efficient, equitable, and effective healthcare system for everyone. The high price of healing doesn’t have to be a barrier; with the right approach, we can make it a testament to our commitment to a healthier future.

References:

https://www.fda.gov/about-fda/histories-fda-regulated-products/history-drug-regulation

https://actuary.org/wp-content/uploads/2018/05/PrescriptionDrugs.030718.pdf

https://spbatpa.org/article/everything-you-wanted-know-about-tpas-were-afraid-ask

https://www.aha.org/news/blog/2024-05-22-drug-prices-and-shortages-jeopardize-patient-access-quality-hospital-care

In this iPMI Global Executive Interview, Christopher Knight, CEO, iPMI Global, met with Mike Rizo, CEO, PharmCare Services. They discussed PharmCare Services role as an International Pharmaceutical Manager (IPM) and the evolution from a training and staffing company to a global provider of specialized therapies, emphasizing their mission to align medication management with improved patient outcomes and cost-efficiency worldwide. 

Please introduce yourself and background in the international healthcare insurance market:

My name is Mike Rizo, and I am the CEO of PharmCare Services. My professional journey has been rooted in creating sustainable, scalable healthcare solutions that bridge gaps in access, cost, and continuity of care. Over the past two decades, I’ve focused on advancing pharmaceutical management in healthcare delivery systems— more-so internationally in the last decade. Our mission at PharmCare Services has always been to design innovative strategies that align medication management with improved patient outcomes, while ensuring cost-efficiency and operational clarity for our partners worldwide. With a strong foundation in pharmacological science and healthcare operations, I’ve been privileged to lead our organization in forming cross-border alliances that redefine the standards for specialty pharmacy care in international markets.

PharmCare Services (PCS) was founded in 2005 as a company focused on the training and staffing of pharmacy professionals, and later as a specialty pharmacy providing highly specialized therapies in Florida, mainly to managed care groups and US insurance payers. Over time, we have evolved to meet the needs of our global clients—insurance companies with international coverage and physical offices in the U.S., Europe, and Latin America. We have immediate access to a network of over 65,000 pharmacies across the United States, Brazil, Ecuador, Colombia, Mexico, and Europe. We own pharmaceutical wholesalers, specialty pharmacies, and infusion suites in the U.S.A., Europe, and Latin America. From our humble beginnings, we have become an International Pharmaceutical Manager (IPM) that serves patients, providers, third-party administrators (TPAs), and international insurance companies alike.

What is your company’s strategy for expanding international pharmaceutical management (IPM) services in international markets, especially in regions with emerging healthcare systems?

We have a multinational, multidisciplinary team that maintains a physical presence in the United States, Europe, and Latin America. Besides having people with feet on the ground in the communities and markets we are trying to serve, we provide interconsultation between medical professionals across borders to streamline the flow of communication and information. This service helps spread the reach and breadth of knowledge available in areas and markets where, previously, it was hard to access. The expansion of services is proportional to the expansion of information. We are starting to serve Africa, the Middle East, and Asia in 2026.

How do you adapt your IPM model to align with the healthcare infrastructure and regulatory environments of different countries?

We stay up-to-date on the latest regulations for each country, and apply a solution-based, constantly evolving, approach. The pharmaceutical and healthcare industry is in a state of constant change, so being able to adapt as the need arises is crucial.

How does your organization ensure affordable medication access in countries where drug pricing and reimbursement structures differ significantly from the U.S.?

We are always looking for the most cost-effective solution to any situation, as long as that solution does not sacrifice the quality or intensity of care that the patient needs. Sometimes medication affordability is rigid, and though reducing costs is one our primary goals, it is never at the expense of the patient.

What role does your IPM play in negotiating drug prices internationally, and how do you manage relationships with multinational pharmaceutical manufacturers?

Since our locations are strategically located in different parts of the U.S.A., Latin America, and Europe, and our teams of pharmacists, physicians, and attorneys are experts in their regions, we are able to partner with other manufacturers and distributors to help them with the pharmacovigilance, dispensation, administration, and clinical monitoring of the specialized therapies. This takes the burden from them in infrastructure and allows them to stay compliant in a very regulated industry. This results in efficiency that translates into safety and savings for everyone.

What are the biggest regulatory challenges your IPM faces in global markets, and how are you navigating differing compliance frameworks?

The biggest regulatory challenge we face is the stringent regulatory framework of the pharmaceutical industry combined with the lack of regulatory harmonization. Our industry is the most regulated of the healthcare services, with so many rules and laws conflicting and overlapping in different countries. Though we may not possess the power to change these regulations, we have the ability to be informed, and understand their complexities, so that we can successfully operate within them, and serve the patients who need us. We navigate these compliance frameworks one at a time, crossing our “t’s” and dotting our “i’s,” to try to eliminate any complications before they arise. Attentive and informed is the only way through.

How does your company ensure ethical and transparent practices across jurisdictions with varying standards for international pharmaceutical management?

Our team’s top two focuses are cost-reduction for our clients and premier-quality care for their patients. These pursuits are not exclusive and maintaining high ethical and transparency standards is the cornerstone to their achievement. We make information of our operations readily available, and above all, we maintain clear and reliable communication with the patients we serve, keeping them consistently up-to-date on their care.

How are you leveraging technology to standardize IPM operations and patient outcomes across multiple countries and health systems?

We leverage the latest technologies through our development of a state-of-the-art, online pharmaceutical management platform, “PCSRx,” available to both clients and their patients. It provides a clear delineation of pharmaceutical claims by the stages in their lifecycle, easy-to-understand data graphics, and global live-tracking of medications in transit, all with real-time updates. It is the first of its kind.

Are there specific innovations or digital health solutions that you’ve developed or adapted for non-U.S. markets that differ from your domestic strategy?

As stated before, our pharmaceutical management platform will help to revolutionize communication and transparency among all members in the industry, for U.S. and non-U.S. markets alike. We wanted to create a solution that would benefit everybody, not just this or that region.

How does your IPM model address disparities in drug availability and healthcare access in lower- and middle-income countries?

Although we wish it were not so, the reality of the pharmaceutical industry is that, sometimes, certain medications and services are not available everywhere they are needed. At PharmCare Services, however, we are actively working to make it so that wherever one can get an IPMI policy, you can receive our services. Global access is the goal.

What metrics do you use to evaluate success in international markets—are they focused more on cost containment, clinical outcomes, or system integration?

We are constantly collecting and analysing key performance indicators, optimizing the value of our service to enable better health for the patient, and cost management for our clients. Thus, we have an equal focus on cost containment, clinical outcomes, and system integration. However, if one had to be picked, clinical outcomes is by far the most important, because without the patients we serve being properly taken care of, the rest of the industry and its members lose their relevance. If we can help even one patient, then our purpose and reason for existing is accomplished. Through this, we are then able to reduce costs and integrate varying systems with increasing success.

In this iPMI Global Pharmacy Benefits Management in Focus Article, Johan Porto, Co-Founder and CFO at PharmCare Services, walks us through the history of PharmCare and talks about how they are transforming pharmaceutical care in the international medical and health insurance market.

Over the past decade, PharmCare Services (PCS) has emerged as a leader in transforming the international pharmacy care landscape. Our mission is to assist international clients in discovering innovative ways to redefine pharmaceutical management, focusing not only on cost reduction but also on transparency, optimization, and comprehensive therapy management. We position ourselves as unwavering partners, enabling companies to navigate an increasingly complex prescriptions environment.

An Evolving Landscape: Tackling the Surge in High-Cost Medication Expenses

The continuous rise in pharmacy costs, particularly concerning high-cost medications, presents one of the most significant challenges for international insurers. According to the 2024 Milliman Medical Index, healthcare costs for the average person increased by 6.7% from 2023 to 2024, with pharmacy costs contributing nearly half of this increase. 

At PCS, we understand that effective medication management extends beyond seeking cost-effective alternatives; it involves addressing the entire therapeutic ecosystem. From comprehending cost structures to ensuring proper patient counselling, medication traceability, and pharmaceutical follow-up, we collaborate with companies to find comprehensive solutions that reduce costs and improve outcomes.

Trends and Projections in Medication Use and Spending

Recent trends indicate significant shifts in medication use across various therapeutic areas. The 2024 Milliman Medical Index projects that healthcare costs for a hypothetical family of four will reach $32,066, with prescription drug costs increasing by 13% compared to the previous year. 

This anticipated rise in medication expenditure underscores the importance of strategic oversight and clear cost frameworks. Organizations face a progressively intricate pricing and reimbursement environment as groundbreaking therapies emerge. PCS is dedicated to supporting our partners in overcoming these challenges by providing solutions that enhance efficiency, affordability, and patient care.

Building Strong Partnerships: PCS and EmpiRx Health

As healthcare costs rise and patient needs evolve, strategic collaborations become more essential than ever in driving sustainable change. Recognizing the urgency for innovation and forging strong partnerships is key to delivering impactful solutions. This year PCS formed a significant partnership with EmpiRx Health, combining our expertise in transparent cost management with a commitment to providing high-quality services. Together, we offer insurers, brokers, and third-party administrators (TPAs) cost-effective, transparent solutions that help them achieve better results with reduced expenses. By working collaboratively with our partners, we ensure that patients and companies benefit from optimized, sustainable pharmacy practices.

The pharmacy management landscape has long been dominated by volume-driven models prioritizing profits over patient outcomes. Many traditional PBMs focus on increasing prescription volume without delivering meaningful health improvements. This misalignment has led to a broken system where international plan sponsors face rising costs, patients struggle with affordability, and true healthcare optimization remains out of reach. For example, 40% of U.S. adults have comorbidities, and 60% live with chronic diseases. Despite these challenges, many PBMs profit while patients see little benefit.

At PCS, we differentiate ourselves by delivering high-touch, personalized services that drive better outcomes. Through our partnership with EmpiRx Health, we provide a pharmacist-led, transparent, data-driven approach that ensures cost efficiency while prioritizing patient well-being. Our model is built on a foundation of trust, clarity, and continuous optimization, offering tailored solutions that address both financial and clinical needs.

Expanding Beyond Latin America: A Vision for Global Growth

While our expertise has grown in Latin America, PCS is committed to expanding its reach into new markets, including Asia and Africa. Despite the differences in healthcare systems worldwide, every one of them can benefit from cost-effective solutions that drive meaningful impact. Our business model is built on transparency and clarity, helping clients mitigate costs through thoroughly understanding processes. As we expand into these new regions, we aim to provide practical, results-driven healthcare solutions that benefit patients and companies alike.

A Shared Journey: Improving Processes and Decision-Making Together

One of the most rewarding aspects of our work at PCS is collaborating with our clients. We don’t just provide services; we become trusted allies in their journey toward improvement. By offering the tools and insights needed to optimize high-cost medication management, we help our clients make decisions based on confidence and transparency. Our partnership approach ensures that every step of the way, clients gain new perspectives that allow them to identify potential gaps and discover opportunities for improvement.

A Long-Term Mission: Focusing on Life and Sustainable Care

At PCS, our mission has always been and will always be to contribute to improving life. We are dedicated to expanding our solutions to more companies, giving them a fresh perspective on managing their operations and costs. Through our transparent, reliable services, we help organizations become more efficient in cost and in their ability to deliver better healthcare outcomes.

Our commitment is clear: we are here to be a trusted ally on the ongoing journey toward more sustainable, cost-effective international pharmaceutical care.